North America Blood Glucose Monitoring Devices Market

The report "North America Blood Glucose Monitoring Devices Market by Product Type (Self-monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site, End User (Self/Homecare) - Forecast to 2030", is projected to reach USD 9.93 billion in 2030 from USD 6.52 billion in 2025, at a CAGR of 8.8% during the forecast period.

Browse 150 market data Tables and 40 Figures spread through 250 Pages and in-depth TOC on "North America Blood Glucose Monitoring Devices Market by Product Type (Self-monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site, End User (Self/Homecare) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-blood-glucose-monitoring-devices-market-12917831.html

In North America, the blood glucose monitoring devices market continues to expand alongside the rising number of individuals living with diabetes, particularly Type 2 diabetes. Routine glucose testing has become a standard part of daily disease management, as patients increasingly monitor their condition outside clinical settings. Improvements in monitoring technologies—ranging from continuous glucose monitoring systems to digitally connected meters and data-driven software—have made glucose tracking more practical and precise for everyday use. These developments help patients better understand glucose trends and adjust lifestyle or treatment decisions accordingly. At the same time, higher device prices, limited penetration of advanced technologies in certain care environments, and usability challenges among elderly and newly diagnosed patients may slow adoption in select segments. Even so, the overall market outlook remains positive, supported by steady innovation and sustained demand for reliable glucose monitoring solutions.

Based on product type, the self-monitoring blood glucose systems segment accounted for the largest share in the North America blood glucose monitoring devices market in 2024.

By product type, the North America blood glucose monitoring devices market is divided into four main segments: self-monitoring blood glucose (SMBG) systems, continuous glucose monitoring systems, professional point-of-care devices, and noninvasive products. SMBG systems accounted for the largest share of the market in 2024, driven by their widespread use in day-to-day diabetes management across home care and outpatient settings. SMBG devices remain widely used for routine glucose testing, particularly among patients with Type 2 diabetes, newly diagnosed individuals, and those not requiring continuous monitoring. Their established presence in primary care workflows, patient familiarity, and broad availability through retail pharmacies and online channels have supported sustained adoption across the region. The segment’s strong position is further supported by ongoing product enhancements, including smaller, more portable meters, faster test strip response times, and improved data storage and transfer capabilities, which collectively improve ease of use and reliability for daily glucose monitoring.

Based on application, the diabetes management segment is expected to grow at the highest CAGR during the forecast period in the North America blood glucose monitoring devices market.

By application, the North American blood glucose monitoring devices market is segmented into diabetes management, health & wellness monitoring, and other applications. The diabetes management segment is expected to post the highest CAGR during the forecast period, driven by the high prevalence of Type 1 and Type 2 diabetes across the region and the clinical emphasis on tight glycemic control. In North America, blood glucose monitoring is an integral component of diabetes treatment, supporting insulin dosing, oral medication adjustments, and dietary planning. The growing adoption of continuous glucose monitoring (CGM) systems has further strengthened this segment by enabling real-time glucose tracking, trend analysis, and early identification of hypo- and hyperglycemic events. Regular, structured monitoring enables timely therapeutic interventions, helping patients achieve stable glucose levels and reduce the risk of acute and long-term diabetes-related complications. Additionally, the availability of reliable home-based monitoring solutions has reinforced patient adherence to prescribed diabetes management protocols across the region.

The US is expected to dominate the North America blood glucose monitoring devices market during the forecast period.

The North America blood glucose monitoring devices market is further divided by country into two major countries – the US and Canada. The US leads in market share in North America. This can be attributed to the high prevalence of diabetes, upgraded healthcare infrastructure, and the population's willingness to adopt modern technologies. According to the International Diabetes Federation (IDF) 11th edition, released in 2025, approximately 38.5 million individuals in the US were living with diabetes in 2024, highlighting the significant and sustained demand for accurate and convenient glucose monitoring solutions. The US market's leading role is also attributable to the presence of manufacturers of blood glucose monitors in the country. Rising disposable income in the US is expected to further increase demand for reliable glucose monitors.

Key Players

Prominent players in the North America blood glucose monitoring devices market include Abbott Laboratories (US), Dexcom, Inc. (US), Medtronic (Ireland), Sinocare (China), B.Braun SE (Germany), F. Hoffmann-La Roche Ltd (Switzerland), i-SENS, Inc. (South Korea), Senseonics (US),  Ascensia Diabetes Care Holdings AG (Switzerland), Nipro (Japan), Medical Technology and Devices S.p.A. (Italy), Terumo Corporation (Japan), Nemaura Medical Inc. (UK), LifeScan IP Holdings, LLC (US), and SD Biosensor, INC (South Korea).

Don’t miss out on business opportunities in North America Blood Glucose Monitoring Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/